KRS Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
KRS Capital Management's AMGN Position: Q2 2026 in Review
KRS Capital Management reduced its Amgen (AMGN) stake by 1.3% in Q2 2026, selling an estimated $15.4K and leaving 3,320 shares worth $1.2M. The position accounts for 0.56% of the portfolio, ranked #31.
KRS Capital Management first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.27M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- KRS Capital Management held 3,320 shares of Amgen worth $1.2M as of Q2 2026.
- KRS Capital Management sold 45 Amgen shares in Q2 2026, an estimated $15.4K.
- Amgen made up 0.56% of KRS Capital Management's portfolio in Q2 2026, its #31 holding.
- KRS Capital Management first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- KRS Capital Management's Amgen position peaked at $1.27M in Q3 2024.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on KRS Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.